# Page 1
In the financial year 2024-25
Divisional Reference Service Hospital, Nashik Karita
31 - Assistant under Heading 2210K088
Subsidies (non-payment) Inj. Centhaquine Citrate
1.0mg to purchase the drug
Rs. 49,25,000 - Administrative for such amount
regarding the approval.
Government of Maharashtra
Department of Public Health
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
10th Floor, GoT Hospital Complex Building,
New Mantralaya, Mumbai - 400001.
Date: July 25, 2024.
Read: -
1.सहस Letter from the Director of Health Services (Hospitals - State Level), Mumbai No. By / Room-3 / T-4 / Nasti No. 19 / Visanseru Amravati Nashik / 2921-23/2024 Inj. Centhaquine Citrate 1.0 mg / d. 28.02.2024
2.सहस Letter from the Director of Health Services (Hospitals - State Level), Mumbai No. By / Room-3 / T-4 / Nasti No. 19 / Visanseru Amravati Nashik / 10905-06/2024 Inj. Centhaquine Citrate 1.0 mg / d. 09.05.2024.
Government Decision, Public Health Department No. PASHAMA-1224 / P.No.41 / Health-8, D. 12.06.2024
4. GOVERNMENT NO. SDL-2019 / Q. 181 / Health-8, D. 29.12.2023
The Proposal: -
The Joint Director of Health Services (Hospitals - State Level), Mumbai has issued the serial number No. 01 and
Departmental Reference in the financial year 2024-25 as per the proposal submitted under letter 02.
Sewa Hospital Nashik and Amravati Mumbai Graduates, Konkan Division Graduates, Nashik Division
The division is held as elections are being held for the posts of teachers as well as the Mumbai Teachers' Constituency.
A model code of conduct was put in place. Divisional Reference Service Hospital Nashik
For Departmental Reference Services Hospital Amravati, except under headings 2210K088, 31 -
Under the objective of Auxiliary Grants (Post-Wage), Inj. Purchase of Centhaquine Citrate 1.0 mg
Read on to know the government's decision in serial number 03. Administrative approval under 12.06.2024
was given.
# Page 2
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
2. Now that the Model Code of Conduct for the aforesaid election has come to an end,
Divisional Reference Service Hospital, Nashik for Inj. The drug is Centhaquine Citrate 1.0 mg.
31 - Subsidiary Grants (Post Salary) under Heading 2210K088 for an amount of Rs. 49,25,000 -
The government was considering granting administrative approval for the purchase of such an amount.
The Government's Decisions:
3. (1) Submitted by the Joint Director of Health Services (Hospitals - State Level), Mumbai
According to the proposal, Inj., for the Divisional Reference Service Hospital, Nashik. Centhaquine Citrate 1.0 mg or
Drug accounting under heading 2210K088 31 - Subsidiary Grants (Post-Wage) under this Objective
Expenditure is expected to be Rs. 49,25,000 and the expenditure is estimated to be Rs. 2024-25 in the current financial year.
This will be met from the grants sanctioned and available under the Accounting Act.
(2) The details of the subsidy and purchase for the said purchase are as follows: -
the prospectus
A - Details of the grant
(Amount in Rupees)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| A. No. | Account Header                                                                                                                                                                                                                                                                                                           | Purchase Details                 | The total cost of the proposal for administrative approval (Rs.) | Available funds                                     |
| 1      | Demand No.R-1, 2210, Medical Services and Public Health, (09) Maharashtra Medical Commodities Procurement Authority, (09) (02) Procurement of Drugs, Pharmaceuticals, Machinery and Equipment through Maharashtra Medical Commodities Procurement Authority 31 - Subsidiary Grants (Non-Payment) (Programme) (2210K 088) | Inj. Centhaquine Citrate 1. 0 mg | Rs 49,25,000                                                     | Year 2024-25 Supplementary Demand (Monsoon Session) |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Page 2 of 5
# Page 3
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
the prospectus
B - Details of the purchase
(Amount in Rupees)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| A. No. | Account Header                                                                                                                                                                                                                                                                                                           | Details of the purchase          | Estimated rate per ng | The required number of | Proposal for administrative approval |
| 1      | Demand No.R-1, 2210, Medical Services and Public Health, (09) Maharashtra Medical Commodities Procurement Authority, (09) (02) Procurement of Drugs, Pharmaceuticals, Machinery and Equipment through Maharashtra Medical Commodities Procurement Authority 31 - Subsidiary Grants (Non-Payment) (Programme) (2210K 088) | Inj. Centhaquine Citrate 1. 0 mg | 9850                  | 500                    | 49,25,000                            |
| Total  | 49,25,000                                                                                                                                                                                                                                                                                                                |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
4. The Commissioner, Commissionerate of Health Services, Mumbai, in connection with the proposal,
The manufacturer issued a letter dated 09.04.2024 to Inj. Centhaquine Citrate is 1.0 mg.
Proprietary Article Certificate and Patent of the Company Owned Drug
The certificate (Patent Number 282155) has been submitted. Also Maharashtra Medical Supplies Procurement
The authority in. Centhaquine Citrate "Single Source" Direct Procurement Process
For the purpose, the Department of Industry, Power and Labour, Government of India, vide its decision dated 01/12/2016, vide Paragraph No.
A signed certificate of Annexure-13 as mentioned in 3.2.6 (Single Source Purchase) is submitted.
Single source procurement submitted by Joint Director Health Services (Hospitals - State Level), Mumbai.
According to the proposal, the procurement will be done through a single source method, subject to the following administrative conditions:
Approval is being given to: -
(1) The requirement / demand for such drugs shall be verified / verified.
Only then should the tender process be carried out for the purchase of these items.
(2) It shall be ensured that the prescriptions for such drugs are as required and up to date. Purchase
Technical Specification of matters to be done by the concerned experts (Technical Committee /
officer) should be in accordance with the direction agreed upon. Also, the technical
specification) is not designed to benefit any particular company.
It has to be verified. Only then should these items be purchased.
Page 3 of 5
# Page 4
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
(3) Government Decisions, Industries, Power and Labour Department, No.Bhankhas-2014 / No.82 / Part-III / Industries-4,
Offices to be conducted by Government Departments notified vide Notification dated 1st December, 2016
Procurement in the prescribed manner as provided in the Revised Manual of Procedure for Procurement
Chief Executive Officer, Maharashtra Medical Procurement with full responsibility for the execution of the process.
The Authority will be headed by the Joint Director of Health Services (Hospitals - State Level), Mumbai.
(4) The proposed purchase rates are estimated at the time of administrative approval. So the price at the end of the purchase process
to be determined. If the rate is below the market price and the supplier concerned
To ensure that the rate at which the item is supplied is not higher than the rate at which it is supplied elsewhere.
Come.
(5) Pre / Post dispatch of items to be purchased
Purchase only items with proper and appropriate specifications by random sample inspection.
Be sure to do that.
(6) Storage and distribution of items to be purchased after supply.
distribution, as well as supply chain management and inventory.
Inventory management should be done in a proper manner so that these things are not left unutilized.
It should be ensured that they are used within the stipulated time.
(7) The purchase is estimated at Rs. The expected cost is 49,25,000 / - and the cost is 2024-25.
31 - Subsidiary Grants (Post-Payment) under Heading 2210K088 for the financial year under this objective.
From the funds made available through Supplementary Demand during the Monsoon Session in 2024-25
to be divided. Ensure that the purchase is completed within the prescribed time frame of administrative approval.
Also, it should be ensured that the purchase of these items does not lead to duplication.
(8) Central Vigilance Commission (CVC) guidelines while implementing the entire procurement process.
It should be followed strictly.
(9) The cost of this work, "Demand No. R-1, 2210, Medical Services and Public Health, (09)
Maharashtra Medical Commodities Procurement Authority, (09) (02) through Maharashtra Medical Commodities Procurement Authority
Procurement of Drugs, Pharmaceuticals, Machinery and Equipment 31 - Subsidiary Grants (Non-Payment) (Programme)
Supplements sanctioned in the financial year 2024-25 under the head "(2210K088)"
In the case of expenditure under such head of accounts, it shall be met from the provision made available by demand.
Come.
(10) Government Decision, Department of Finance, No.2013 / No.30 / Part - 2/2013 Regulations, dated 17th April,
The Financial Rights Manual, 1978 in the Annexure with 2015, Part-I, Sub-section-II
A. No. 4 Rule No. 7 Front Column No. 6 The conditions here must be met.
Page 4 of 5
# Page 5
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
(11) The purchase shall be made through the Maharashtra Medical Supplies Procurement Authority, Mumbai.
The Authority shall submit the details to the Government after completion of the tendering process submitted.
6. The above paragraph No. The Commissioner, Commissionerate of Health Services, Mumbai, the CEO, Maharashtra Medical Supplies Procurement Authority, Mumbai and the Joint Director Health Services (Hospitals-State Level), Mumbai shall be solely responsible for ensuring that the conditions mentioned in Roll No. 1 to 11 of No. 5 are met and the procurement is as per the rules and requirements.
Government Decisions, Department of Finance, No.2013 / No. 30/13 Regulations, Part-II, dated 17th April,
Article No. 4 of the Financial Rights Manual 1978 Part-I Sub-section-II, 2015
Rule No. 7 to allow the purchase of implements, retail equipment and activity sets.
Full powers have been delegated to the administrative division.
The Government decision is available on the Government of Maharashtra website www.maharashtra.gov.in.